The North America region continues to play a significant role in the growth of the Syndromic Multiplex Diagnostic Market. The presence of advanced healthcare infrastructure, increasing adoption of molecular diagnostic technologies, and strong focus on rapid disease detection have contributed to the region’s market expansion. Healthcare providers across North America are increasingly...